1-2 of 2
Joseph L. Roswarski
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Single-Agent Mosunetuzumab Produces High Complete Response Rates in Patients with Newly Diagnosed Follicular Lymphoma: Primary Analysis of the Mithic-FL1 Trial

Lorenzo Falchi, Michelle Okwali, Alexandra Ferreira Lopes, Paul A. Hamlin, Jennifer Kimberly Lue, Paola Ghione, Colette Owens, Pallawi Torka, Anita Kumar, Raphael Steiner, Zachary D. Epstein-Peterson, Maria Lia Palomba, Robert Stuver, Ariela Noy, Anastasia Martinova, Lauren Wood, Clare Grieve, Walter Ramos Amador, Santosha A. Vardhana, Andrew D. Zelenetz, Lori A. Leslie, Joseph L. Roswarski, Kieron Dunleavy, Andre Goy, Gilles Salles
Journal: Blood
Blood (2024) 144 (Supplement 1): 340.
https://doi.org/10.1182/blood-2024-205046
Published: 2024
Journal Articles

Fixed Duration Combination Therapy with Carfilzomib, Lenalidomide, and Dexamethasone Followed By Lenalidomide Maintenance Leads to High Rates of Sustained MRD Negativity in Patients with High-Risk Smoldering Multiple Myeloma: Long Term Follow up of an Investigator Initiated Phase 2 Trial

Elizabeth Hill, Joseph L. Roswarski, Amrit Bhaskarla, Alexander Dew, Candis Morrison, Michael Emanuel, Ani Petrosyan, Hao-Wei Wang, Constance M. Yuan, Liza Lindenberg, Esther Mena, Baris Turkbey, Nisha Patel, Irina Maric, Alina Dulau-Florea, Katherine Calvo, Raul C. Braylan, Maryalice Stetler-Stevenson, Seth M. Steinberg, William Figg, Ryan M. Young, Ola Landgren, Mark Roschewski, Dickran Kazandjian
Journal: Blood
Blood (2023) 142 (Supplement 1): 337.
https://doi.org/10.1182/blood-2023-181811
Published: 2023